These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 25882872)

  • 41. The epidemiology of paediatric intussusception in Singapore: 1997 to 2004.
    Boudville IC; Phua KB; Quak SH; Lee BW; Han HH; Verstraeten T; Bock HL
    Ann Acad Med Singap; 2006 Oct; 35(10):674-9. PubMed ID: 17102889
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Intussusception risk following oral monovalent rotavirus vaccination in 3 Asian countries: A self-control case series evaluation.
    Burnett E; Riaz A; Anwari P; Myat TW; Chavers TP; Talat N; Safi N; Aung NNT; Cortese MM; Sultana S; Samsor A; Thu HM; Saddal NS; Safi S; Lin H; Qazi SH; Safi H; Ali A; Parashar UD; Tate JE
    Vaccine; 2023 Nov; 41(48):7220-7225. PubMed ID: 37884416
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-marketing surveillance of intussusception after Rotarix administration in Afghanistan, 2018-2022.
    Anwari P; Burnett E; Chavers TP; Samsor A; Safi H; Safi N; Clark AD; Parashar UD; Tate JE
    Vaccine; 2024 Mar; 42(8):2059-2064. PubMed ID: 38413278
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Evaluation of Intussusception after Monovalent Rotavirus Vaccination in Africa.
    Tate JE; Mwenda JM; Armah G; Jani B; Omore R; Ademe A; Mujuru H; Mpabalwani E; Ngwira B; Cortese MM; Mihigo R; Glover-Addy H; Mbaga M; Osawa F; Tadesse A; Mbuwayesango B; Simwaka J; Cunliffe N; Lopman BA; Weldegebriel G; Ansong D; Msuya D; Ogwel B; Karengera T; Manangazira P; Bvulani B; Yen C; Zawaira FR; Narh CT; Mboma L; Saula P; Teshager F; Getachew H; Moeti RM; Eweronu-Laryea C; Parashar UD;
    N Engl J Med; 2018 Apr; 378(16):1521-1528. PubMed ID: 29669224
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia.
    Buttery JP; Danchin MH; Lee KJ; Carlin JB; McIntyre PB; Elliott EJ; Booy R; Bines JE;
    Vaccine; 2011 Apr; 29(16):3061-6. PubMed ID: 21316503
    [TBL] [Abstract][Full Text] [Related]  

  • 46. More on RotaShield and intussusception: the role of age at the time of vaccination.
    Simonsen L; Viboud C; Elixhauser A; Taylor RJ; Kapikian AZ
    J Infect Dis; 2005 Sep; 192 Suppl 1():S36-43. PubMed ID: 16088803
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Rotavirus vaccines: a story of success.
    Kollaritsch H; Kundi M; Giaquinto C; Paulke-Korinek M
    Clin Microbiol Infect; 2015 Aug; 21(8):735-43. PubMed ID: 25680314
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Benefit Versus Risk Assessment of Rotavirus Vaccination in France: A Simulation and Modeling Analysis.
    Ledent E; Arlegui H; Buyse H; Basile P; Karkada N; Praet N; Nachbaur G
    BioDrugs; 2018 Apr; 32(2):139-152. PubMed ID: 29589230
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Intussusception-related Hospitalizations Among Infants Before and After Private Market Licensure of Rotavirus Vaccines in Taiwan, 2001-2013.
    Yen C; Shih SM; Tate JE; Wu FT; Huang YC; Parashar UD; Hsiung CA
    Pediatr Infect Dis J; 2017 Oct; 36(10):e252-e257. PubMed ID: 28640005
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Safety of the pentavalent rotavirus vaccine (PRV), RotaTeq(®), in Kenya, including among HIV-infected and HIV-exposed infants.
    Laserson KF; Nyakundi D; Feikin DR; Nyambane G; Cook E; Oyieko J; Ojwando J; Rivers SB; Ciarlet M; Neuzil KM; Breiman RF
    Vaccine; 2012 Apr; 30 Suppl 1():A61-70. PubMed ID: 22520138
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Post-Marketing Benefit-Risk Assessment of Rotavirus Vaccination in Japan: A Simulation and Modelling Analysis.
    Ledent E; Lieftucht A; Buyse H; Sugiyama K; Mckenna M; Holl K
    Drug Saf; 2016 Mar; 39(3):219-30. PubMed ID: 26748506
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules.
    Clark A; Tate J; Parashar U; Jit M; Hasso-Agopsowicz M; Henschke N; Lopman B; Van Zandvoort K; Pecenka C; Fine P; Sanderson C
    Lancet Glob Health; 2019 Nov; 7(11):e1541-e1552. PubMed ID: 31607466
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Risk of intussusception following rotavirus vaccination: An evidence based meta-analysis of cohort and case-control studies.
    Kassim P; Eslick GD
    Vaccine; 2017 Jul; 35(33):4276-4286. PubMed ID: 28648544
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Changing epidemiology of intussusception in Australia.
    Justice F; Carlin J; Bines J
    J Paediatr Child Health; 2005; 41(9-10):475-8. PubMed ID: 16150062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Impact of rotavirus vaccination on intussusception hospital admissions in England.
    McGeoch LJ; Finn A; Marlow RD
    Vaccine; 2020 Jul; 38(35):5618-5626. PubMed ID: 32654906
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Risk of intussusception after monovalent rotavirus vaccination.
    Weintraub ES; Baggs J; Duffy J; Vellozzi C; Belongia EA; Irving S; Klein NP; Glanz JM; Jacobsen SJ; Naleway A; Jackson LA; DeStefano F
    N Engl J Med; 2014 Feb; 370(6):513-9. PubMed ID: 24422678
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Rotavirus vaccination: a risk factor for intussusception?
    Oberle D; Jenke AC; von Kries R; Mentzer D; Keller-Stanislawski B
    Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz; 2014 Feb; 57(2):234-41. PubMed ID: 24469287
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hospital-based surveillance of intussusception among infants.
    Fernandes EG; Leshem E; Patel M; Flannery B; Pellini AC; Veras MA; Sato HK
    J Pediatr (Rio J); 2016; 92(2):181-7. PubMed ID: 26804014
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Addition of history of intussusception as a contraindication for rotavirus vaccination.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Oct; 60(41):1427. PubMed ID: 22012117
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Rotavirus vaccines and intussusception risk.
    Bines JE
    Curr Opin Gastroenterol; 2005 Jan; 21(1):20-5. PubMed ID: 15687880
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.